metabolic health

Cranberry Cardiometabolic Meta-Analysis Evidence Table

Structured evidence table for Cranberry Cardiometabolic Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Cranberry Cardiometabolic Meta-AnalysisIntroduction Dietary (poly)phenols have beneficial properties that may play a relevant role in the management of overweight/obesity and cardiometabolic risk factors, modulating physiological and molecular pathways involved in energy metabolism, adiposity and gut microbiota-derived metabolites.2Lanuza F (2025)Effect of plant-based foods and (poly)phenol supplementation on gut-microbiota metabolism in participants with overweight or obesity and cardiometabolic risk: a study protocol for a single-blind, parallel and randomised controlled trial.
Cranberry Cardiometabolic Meta-AnalysisThe study will evaluate the effectiveness of a healthy plant-based diet (PBD) rich in (poly)phenols compared with (poly)phenol supplementation during a caloric restriction intervention.A total of 99 adults (aged 25-45 years) with overweight or obesity (body mass index: 25-35 kg/m²) and cardiovascular risk factors will be recruited from primary health centres in Temuco, Araucanía Region, Chile.2Lanuza F (2025)Effect of plant-based foods and (poly)phenol supplementation on gut-microbiota metabolism in participants with overweight or obesity and cardiometabolic risk: a study protocol for a single-blind, parallel and randomised controlled trial.
Cranberry Cardiometabolic Meta-AnalysisMethods and analysis The Prevention/Precision Diet in Araucanía (PREDIET-ARAC) trial is a randomised, single-blind, parallel arm, placebo-controlled, clinical trial designed to assess the potential health benefits of (poly)phenol intake through either diet or supplementation.2Lanuza F (2025)Effect of plant-based foods and (poly)phenol supplementation on gut-microbiota metabolism in participants with overweight or obesity and cardiometabolic risk: a study protocol for a single-blind, parallel and randomised controlled trial.
Cranberry Cardiometabolic Meta-AnalysisFurthermore, PAC proved effective in alleviating key risk factors associated with cardiovascular diseases by diminishing plasma saturated fatty acids, as well as levels of triglycerides, cholesterol, and non-HDL-C levels.4Feldman F (2025)Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.
Cranberry Cardiometabolic Meta-AnalysisTo better clarify the mechanisms behind PAC actions, gut-liver axis parameters were examined, showing significant enhancements in gut microbiota composition, microbiota-derived metabolites, and marked reductions in intestinal and hepatic inflammation, liver steatosis, and key biomarkers associated with endoplasmic reticulum (ER) stress and lipid metabolism.4Feldman F (2025)Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.
Cranberry Cardiometabolic Meta-AnalysisMetabolic syndrome (MetS) constitutes a spectrum of interconnected conditions comprising obesity, dyslipidemia, hypertension, and insulin resistance (IR).4Feldman F (2025)Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.
Cranberry Cardiometabolic Meta-AnalysisWhile a singular, all-encompassing treatment for MetS remains elusive, an integrative approach involving tailored lifestyle modifications and emerging functional food therapies holds promise in preventing its multifaceted manifestations.4Feldman F (2025)Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.
topicCranberry Cardiometabolic Meta-Analysis
claimIntroduction Dietary (poly)phenols have beneficial properties that may play a relevant role in the management of overweight/obesity and cardiometabolic risk factors, modulating physiological and molecular pathways involved in energy metabolism, adiposity and gut microbiota-derived metabolites.
evidence level2
citationLanuza F (2025)
sourceEffect of plant-based foods and (poly)phenol supplementation on gut-microbiota metabolism in participants with overweight or obesity and cardiometabolic risk: a study protocol for a single-blind, parallel and randomised controlled trial.
topicCranberry Cardiometabolic Meta-Analysis
claimThe study will evaluate the effectiveness of a healthy plant-based diet (PBD) rich in (poly)phenols compared with (poly)phenol supplementation during a caloric restriction intervention.A total of 99 adults (aged 25-45 years) with overweight or obesity (body mass index: 25-35 kg/m²) and cardiovascular risk factors will be recruited from primary health centres in Temuco, Araucanía Region, Chile.
evidence level2
citationLanuza F (2025)
sourceEffect of plant-based foods and (poly)phenol supplementation on gut-microbiota metabolism in participants with overweight or obesity and cardiometabolic risk: a study protocol for a single-blind, parallel and randomised controlled trial.
topicCranberry Cardiometabolic Meta-Analysis
claimMethods and analysis The Prevention/Precision Diet in Araucanía (PREDIET-ARAC) trial is a randomised, single-blind, parallel arm, placebo-controlled, clinical trial designed to assess the potential health benefits of (poly)phenol intake through either diet or supplementation.
evidence level2
citationLanuza F (2025)
sourceEffect of plant-based foods and (poly)phenol supplementation on gut-microbiota metabolism in participants with overweight or obesity and cardiometabolic risk: a study protocol for a single-blind, parallel and randomised controlled trial.
topicCranberry Cardiometabolic Meta-Analysis
claimFurthermore, PAC proved effective in alleviating key risk factors associated with cardiovascular diseases by diminishing plasma saturated fatty acids, as well as levels of triglycerides, cholesterol, and non-HDL-C levels.
evidence level4
citationFeldman F (2025)
sourceTherapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.
topicCranberry Cardiometabolic Meta-Analysis
claimTo better clarify the mechanisms behind PAC actions, gut-liver axis parameters were examined, showing significant enhancements in gut microbiota composition, microbiota-derived metabolites, and marked reductions in intestinal and hepatic inflammation, liver steatosis, and key biomarkers associated with endoplasmic reticulum (ER) stress and lipid metabolism.
evidence level4
citationFeldman F (2025)
sourceTherapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.
topicCranberry Cardiometabolic Meta-Analysis
claimMetabolic syndrome (MetS) constitutes a spectrum of interconnected conditions comprising obesity, dyslipidemia, hypertension, and insulin resistance (IR).
evidence level4
citationFeldman F (2025)
sourceTherapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.
topicCranberry Cardiometabolic Meta-Analysis
claimWhile a singular, all-encompassing treatment for MetS remains elusive, an integrative approach involving tailored lifestyle modifications and emerging functional food therapies holds promise in preventing its multifaceted manifestations.
evidence level4
citationFeldman F (2025)
sourceTherapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.

Learn next

Related evidence and supplement guides

GuideLion's Mane Mushroom: What the Evidence Actually Shows for Brain HealthLegacy library material — check the original sources.GuideNMN and NR: What the Nicotinamide Adenine Dinucleotide Supplements Actually PromiseLegacy library material — check the original sources.GuideCoQ10 (Ubiquinol vs Ubiquinone): Who Benefits and What the Evidence ShowsLegacy library material — check the original sources.GuideCollagen Supplements: What They Can and Cannot Do for Skin and JointsLegacy library material — check the original sources.AnswerWhat does the evidence say about Cranberry Cardiometabolic Meta-Analysis?Legacy library material — check the original sources.AnswerWhat does the evidence say about Amla Cardiometabolic Meta-Analysis?Legacy library material — check the original sources.AnswerWhat does the evidence say about Chia Seed Cardiometabolic Meta-Analysis?Legacy library material — check the original sources.AnswerWhat does the evidence say about Cinnamon Cardiometabolic Meta-Analysis?Legacy library material — check the original sources.

Source documents

  1. Effect of plant-based foods and (poly)phenol supplementation on gut-microbiota metabolism in participants with overweight or obesity and cardiometabolic risk: a study protocol for a single-blind, parallel and randomised controlled trial.
  2. Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.